MedPath

四川美大康佳乐药业有限公司

Ownership
-
Established
2001-08-28
Employees
-
Market Cap
-
Website
www.medcalo.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

103

NMPA:103

Drug Approvals

Nimodipine Injection

Product Name
尼莫地平注射液
Approval Number
国药准字H20254339
Approval Date
May 27, 2025
NMPA

Tedizolid Phosphate for Injection

Product Name
注射用磷酸特地唑胺
Approval Number
国药准字H20249760
Approval Date
Dec 17, 2024
NMPA

Ketorolac Trometamol Injection

Product Name
酮咯酸氨丁三醇注射液
Approval Number
国药准字H20237117
Approval Date
Jun 14, 2024
NMPA

Urapidil Hydrochloride Injection

Product Name
盐酸乌拉地尔注射液
Approval Number
国药准字H20243481
Approval Date
Apr 11, 2024
NMPA

Urapidil Hydrochloride Injection

Product Name
盐酸乌拉地尔注射液
Approval Number
国药准字H20243482
Approval Date
Apr 11, 2024
NMPA

Linezolid and Glucose Injection

Product Name
利奈唑胺葡萄糖注射液
Approval Number
国药准字H20193094
Approval Date
Jan 10, 2024
NMPA

Linezolid and Glucose Injection

Product Name
利奈唑胺葡萄糖注射液
Approval Number
国药准字H20193093
Approval Date
Jan 10, 2024
NMPA

Sodium Bicarbonate Ringer's Injection

Product Name
碳酸氢钠林格注射液
Approval Number
国药准字H20223649
Approval Date
Dec 18, 2023
NMPA

Levofloxacin Lactate Injection

Product Name
乳酸左氧氟沙星注射液
Approval Number
国药准字H20093629
Approval Date
Dec 1, 2023
NMPA

Levofloxacin Lactate Injection

Product Name
乳酸左氧氟沙星注射液
Approval Number
国药准字H20093630
Approval Date
Nov 30, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 11
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.